Trial intelligence / Profile preview

LF111 (drospirenone) vs desogestrel for oral contraception over 9 cycles

2011-002396-42Phase 3Completed

Sponsor
Laboratorios Leon Farma
Start
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of drospirenone (2 arms), sponsored by Laboratorios Leon Farma. Primary endpoint: Overall Pearl Index. Started Dec 2011; status: completed.

02

Drugs

drospirenone

Beyond the preview

Go deeper on 2011-002396-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-002396-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call